SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is experiencing a surge in attention following reports of a strategic partnership with Novo Nordisk to distribute weight-loss drugs, resolving their prior dispute. The market is now actively discussing the potential for a significant short squeeze, fueled by high short interest and the dramatic nature of this unexpected collaboration.

Aventus Network

Aventus Network (AVT) is capturing attention following the formal incorporation of its DAO in the UAE and strategic partnerships to bolster its Aventus Cloud offerings. The community is buzzing about AVT's enterprise-grade technology, Polkadot integration, and low market capitalization, anticipating a significant breakout.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is currently a major focus amid escalating geopolitical tensions with Iran, which have significantly disrupted oil tanker traffic through the critical Strait of Hormuz. The market is keenly watching for whether this signals a prolonged supply squeeze or a temporary "fear premium" that could be quickly reversed by a resolution or market intervention.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI ($FAI) is rapidly gaining attention following a significant price surge, with "great AI news" and the overall enthusiasm for AI crypto driving the conversation. Community members are actively debating its potential for exponential growth against concerns of high volatility, with its presence on the Base network adding to the speculative interest.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is generating buzz due to increasing community confidence in Miplyffa's impending European approval and robust U.S. sales momentum, alongside the strategic appointment of a new CFO seen as a catalyst for enhanced commercialization and potential M&A activity.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending amid reports of a partnership with Hims & Hers to distribute its weight-loss drugs and recent FDA crackdowns on unapproved compounded GLP-1s, bolstering branded market share. The community is discussing NVO's perceived undervaluation and the rapid adoption of its oral Wegovy, despite its stock's more muted reaction compared to its new partner's.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending on high community expectations for a blowout earnings report and its imminent inclusion in the S&P 100, driven by insatiable AI-fueled demand for High Bandwidth Memory that is sold out through 2026, prompting many to "buy the dip" amidst broader market volatility.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending amid intense community discussion surrounding the anticipated "Clarity Act," with many believing its passage will establish the token as a vital digital commodity for collateralized payments and drive significant institutional adoption. This bullish outlook, however, is heavily counterbalanced by widespread frustration and skepticism over AMP's persistent downtrend and historical price volatility among long-term holders.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending as investors digest its recent positive earnings, significant debt reduction, and the game-changing acquisition of Valaris, positioning it as a deepwater drilling powerhouse. The community is actively discussing perceived undervaluation and frustration over the stock's current price action, which many feel is disconnected from surging oil prices driven by escalating geopolitical tensions.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF (UVXY) is trending due to heightened geopolitical tensions, particularly surrounding the US and Iran, which is driving discussions around market volatility. The community is actively debating whether to capitalize on potential spikes, with some expecting significant upside, or to short the ETF, viewing it as a 'widowmaker' designed for long-term decay.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Manhattan Associates, Inc. $MANH Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC cut its stake in Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 51.8% during the third quarter, according to its most recent 13F filing with the Securities and...

Stock Buyback Plan Announced by Manhattan Associates (NASDAQ:MANH)

Manhattan Associates (NASDAQ:MANH - Get Free Report) announced that its board has initiated a stock buyback program on Thursday, March 5th, RTT News reports. The company plans to repurchase $500.00...

Manhattan Associates Board Approves Expansion Of Share Repurchase Program, Stock Up

(RTTNews) - Manhattan Associates, Inc. (MANH), Thursday announced that its Board has approved the expansion of share repurchase program to $500 million from $100 million, effective immediately...

Manhattan Associates Increases Share Repurchase Program to US$500 Million

Today, Manhattan Associates Inc. (NASDAQ: MANH) announced that its board of directors approved an increase in the companys common share repurchase authority from $100 million to $500 million...

GW&K Investment Management LLC Decreases Holdings in Manhattan Associates, Inc. $MANH

GW&K Investment Management LLC trimmed its holdings in shares of Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 20.5% during the third quarter, according to its most recent 13F filing with...

Citigroup Inc. Sells 17,103 Shares of Manhattan Associates, Inc. $MANH

Citigroup Inc. decreased its position in Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 43.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...

Segall Bryant & Hamill LLC Buys 30,794 Shares of Manhattan Associates, Inc. $MANH

Segall Bryant & Hamill LLC grew its stake in shares of Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 43.8% during the 3rd quarter, according to the company in its most recent disclosure...

Symbotic's Substantial Backlog Bodes Well, Signals Multi-Year Growth

Symbotic's $22.3B backlog and surging recurring revenue highlight a multi-year growth runway, even as project timing keeps quarterly results fluid.

American Century Companies Inc. Acquires 152,348 Shares of Manhattan Associates, Inc. $MANH

American Century Companies Inc. grew its stake in Manhattan Associates, Inc. (NASDAQ:MANH - Free Report) by 27.7% in the third quarter, according to the company in its most recent 13F filing with the...

Manhattan Associates, Inc. (NASDAQ:MANH) Sees Large Increase in Short Interest

Manhattan Associates, Inc. (NASDAQ:MANH - Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling...

Manhattan Associates, Inc. engages in the business of developing, selling, deploying, servicing, and maintaining software solutions designed to manage supply chains, inventory, and omnichannel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. It operates through the following geographical segments: North and Latin America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Deepak Raghavan in October 1990 and is headquartered in Atlanta, GA.

Current Price	$152.45
Prev Close	$147.00
Open	$145.61
Dividend Yield	0.00%
50-Day Moving Average	$157.32
Beta	1.27
Avg. Volume	1.06M
PE Ratio	40.80

52-Week High	$247.22
52-Week Low	$127.86
Market Capitalization	$8.8B
EPS (Annual)	$3.60
Price to Book	27.95
Revenue Per Employee	$247,458.12

MANH
Manhattan Associates, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MANH News

MANHManhattan Associates, Inc.